Peter Radovich
President at MIRUM PHARMACEUTICALS, INC.
Net worth: 815 909 $ as of 30/04/2024
Peter Radovich active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Chief Operating Officer | 28/04/2020 | - |
| President | 16/01/2024 | - |
Career history of Peter Radovich
Former positions of Peter Radovich
| Companies | Position | Start | End |
|---|---|---|---|
| RAIN ONCOLOGY INC. | Director/Board Member | 01/03/2018 | 25/01/2024 |
| Independent Dir/Board Member | 01/03/2018 | 25/01/2024 | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Operating Officer | 01/09/2016 | 01/04/2020 |
| Corporate Officer/Principal | 01/11/2014 | 01/09/2016 | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Director/Board Member | 01/01/2004 | 01/09/2006 |
| Corporate Officer/Principal | 01/01/2004 | 01/09/2006 | |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/01/2004 | 01/01/2006 |
Training of Peter Radovich
| University of Washington | Masters Business Admin |
| Texas Christian University | Undergraduate Degree |
Statistics
International
| United States | 8 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Director/Board Member | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
- Stock Market
- Insiders
- Peter Radovich
- Experience